14-day Premium Trial Subscription Try For FreeGet Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGRX
Powered by GPT-4
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Agile Therapeutics
(Updated on Dec 08, 2023)

Buy candidate since Dec 01, 2023 Gain 6.48% PDF
The Agile Therapeutics stock price fell by -2.1276595744681% on the last day (Friday, 8th Dec 2023) from $2.35 to $2.30. During the last trading day the stock fluctuated 7.33% from a day low at $2.25 to a day high of $2.42. The price has risen in 6 of the last 10 days and is up by 7.98% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 thousand shares and in total, 33 thousand shares were bought and sold for approximately $75.59 thousand.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.74% during the next 3 months and, with a 90% probability hold a price between $2.02 and $2.95 at the end of this 3-month period.

AGRX Signals & Forecast

The Agile Therapeutics stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.27 and $2.04. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, December 04, 2023, and so far it has fallen -6.88%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Maximize Your Market Edge: Go Premium for In-Depth AI-Powered Stock Research and Exclusive Lists! 🚀

Support, Risk & Stop-loss for Agile Therapeutics stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.06 and $2.02. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Agile Therapeutics finds support just below today's level at $2.06. If this is broken, then the next support from accumulated volume will be at $2.02 and $1.90.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.165 between high and low, or 7.33%. For the last week the stock has had daily average volatility of 14.50%.

Our recommended stop-loss: $2.17 (-5.78%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (AGRX) For The Upcoming Trading Day Of Monday 11th

For the upcoming trading day on Monday, 11th we expect Agile Therapeutics to open at $2.32, and during the day (based on 14 day Average True Range), to move between $2.09 and $2.51, which gives a possible trading interval of +/-$0.210 (+/-9.13%) up or down from last closing price. If Agile Therapeutics takes out the full calculated possible swing range there will be an estimated 18.26% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.40 (4.35%) than the support at $2.06 (10.43%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Agile Therapeutics stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agile Therapeutics stock to perform well in the short-term.

Current score: 3.561 Open Broker Account

Buy Candidate Unchanged

Predicted Opening Price for Agile Therapeutics of Monday, December 11, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price December 11, 2023 Current price
$2.32 $2.30 (Undervalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.49 8.12 %
R2 2.42 5.38 %
R1 2.38 3.68 %
Current price: 2.30
Support S1 2.26 -1.80 %
S2 2.22 -3.49 %
S3 2.16 -6.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.59 12.61 %
R2 2.47 7.39 %
R1 2.40 4.35 %
Current price 2.30
Support S1 2.06 -10.43%
S2 2.02 -12.17%
S3 1.90 -17.39%
What is the symbol for Agile Therapeutics Stock and on which exchange is it traded?
The symbol for Agile Therapeutics is AGRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Agile Therapeutics Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agile Therapeutics stock to perform well in the short-term.

How to buy Agile Therapeutics Stock?
Agile Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Agile Therapeutics Stock.

What's the current price of Agile Therapeutics Stock?
As of the end of day on the 2023-12-08, the price of an Agile Therapeutics (AGRX) share was $2.30.

What is the 52-week high and low for Agile Therapeutics Stock?
The 52-week high for Agile Therapeutics Stock is $9.13 and the 52-week low is $0.175.

What is the market capitalization of Agile Therapeutics Stock?
As of the 2023-12-08, the market capitalization of Agile Therapeutics is 5.902M.

When is the next earnings date for Agile Therapeutics?
The upcoming earnings date for Agile Therapeutics is 2024-03-20 23:00:00.

Click to get the best stock tips daily for free!

About Agile Therapeutics

Agile Therapeutics Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to h... AGRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE